Portfolio company
Quanterix
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops ultra-sensitive biomarker detection platforms and assay kits for pharmaceutical companies, academic institutions, and clinical laboratories.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Alamar Biosciences
This company develops high-sensitivity proteomics platforms and protein biomarker detection assays for life sciences researchers and clinicians in drug development and disease research.
Nplex Biosciences
This company develops high-throughput proteomics platforms for researchers in pharmaceutical and academic sectors to measure proteins for drug and biomarker discovery.
QDTI
This company develops quantum sensing instruments for biomarker detection used by researchers, pharmaceutical companies and clinicians for drug discovery and diagnostic testing.
Range Biotechnologies
This company develops a proteomics platform for high-throughput protein quantification to support pharmaceutical companies and clinical laboratories with drug discovery and diagnostics.
Probius
This company develops bioanalytical platforms using quantum electrochemical spectroscopy to provide biochemical data for pharmaceutical, biotechnology and healthcare researchers.
Proteomics
This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.
Metabolon
This company develops metabolomics profiling kits and analysis services for pharmaceutical, biotechnology, and academic researchers to identify biomarkers and understand biological pathways.
QuantaLife
This company develops digital polymerase chain reaction systems for laboratories to identify and quantify DNA molecules for genetic analysis and disease diagnosis.
